Skip to content

PCIL

Pharma C Investments Plc

Suspended

ISIN

GB00BJDPYD55

Bid

0.13

Mid

0.14

Ask

0.15

Key Information

Price Change
0.00%
Year High
0.14
Year Low
0.14
Last Trade
16 Aug 22
Market Cap
£377.80K
Par
0.00
Bid
0.13
Mid Price
0.14
Ask
0.15
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
269.9M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About Pharma C Investments Plc

The Company was incorporated on 28 August 2018 as an investment vehicle (being a SPAC under the AQSE Growth Market Access Rulebook) to identify investment opportunities and make acquisitions in companies; it is specifically seeking to take advantage of the dynamic regulatory environment surrounding legal Medicinal Cannabis. The Company will focus on identifying investment opportunities in companies that provide ancillary products and services which serve the Medicinal Cannabis sector, not just in Europe, but in markets globally (with a particular focus on the United Kingdom, Europe and Israel) that are internationally recognised as having well- developed and reputable laws and regulations for the research and production of Medicinal Cannabis and that comply with the United Nations’ Convention on Narcotic Drugs. The Company expects to provide investee companies with strategic insights, assist with helping them realise their growth strategy and provide operational support as they develop.

Pharma C Investments PlcAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

16 Aug 22

09:46

1,000,0000.111,100.00

10 Aug 22

11:43

752,6880.13978.49

26 Jul 22

14:57

2,500,0000.153,750.00

26 Jul 22

14:55

2,500,0000.153,750.00

26 Jul 22

10:17

100,0000.16160.00
View all trades

Latest Announcements

DateTitle

22 Feb 23

07:00

Pharma C Investments - Appointment of Director

20 Dec 22

16:30

Pharma C Investments - Result of AGM

24 Nov 22

16:57

Pharma C Investments - Notice of AGM

18 Nov 22

17:26

Pharma C Investments - Half-year Report and Notice of AGM

30 Jun 22

14:23

Pharma C Investments - Annual Financial Report
View all announcements

Address

Registered Address

19 Compton Avenue, London, N1 2XD, United Kingdom

Email

gavin@pharmacinvestments.com

Phone

07897 834092

Contacts

Corporate Adviser

Novum Securities, 2nd Floor Lansdowne House, 57 Berkeley Square, London, W1J 6ER, United Kingdom

Registrar

Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal